Amal Bouziane
Mohammed V University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Amal Bouziane.
Acta Odontologica Scandinavica | 2012
Oum Keltoum Ennibi; Latifa Benrachadi; Amal Bouziane; Dorte Haubek; Knud Poulsen
Abstract Objective: To investigate the presence of A. actinomycetemcomitans, including the highly virulent JP2 clone, in young adult patients with aggressive periodontitis, and associate the findings with the two forms of the disease. Materials and methods: Seventy Moroccan subjects with aggressive periodontitis, aged less than 35 years, were recruited. Among these, 41 had LAgP and 29 had GAgP. Plaque samples were collected from periodontal pockets and examined using a PCR that detects the presence of A. actinomycetemcomitans and which differentiates between JP2 and non-JP2 genotypes of the bacterium. Results : total of 58 (83%) from the 70 AgP patients were positive for A. actinomycetemcomitans, among whom 77% were positives for the JP2 clone. The JP2 clone was detected in 34 (83%) of the LAgP patients compared to 20 (69%) of the GAgP patients (p = 0.17). Fourteen (20%) of the patients harbored non-JP2 genotypes of A. actinomycetemcomitans, although most of these patients (10/14) also harbored the JP2 clone. Conclusions: The presence of the JP2 clone of A. actinomycetemcomitans is strongly associated with both LAgP and GAgP in young adults in Morocco. This implies that treatment of AgP in this population should include microbiological screening and aim at eradication of the bacterium when present.
Medicina Oral Patologia Oral Y Cirugia Bucal | 2013
Oumkeltoum Ennibi; Leila Lakhdar; Amal Bouziane; Yahia Bensouda; Redouane Abouqal
Background: Chlorhexidine is well known for its antiplaque effect. However, the mouthrinse based chlorhexidine antiplaque efficiency may vary according to the formulation of the final product. The aim of the present study was to compare anti-plaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base (CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with 0.1% of Formaldehyde (CLX-F). Material and Methods: the study was a seven day randomized, double-blind, placebo-controlled trial including 30 volunteers. At the start, all participants received a dental prophylaxis. Over 7 days experimental non-brushing period, during which subjects abstained from all forms of mechanical oral hygiene, one group test rinsed twice daily with 15ml of an alcohol base 0.12% Chlorhexidine mouthrinse. The second group test used 15ml of alcohol free 0.1% Chlorhexidine mouthrinse base 0.1% formaldehyde twice daily. The negative control group used a placebo. Plaque indexes were recorded in all volunteers prior to treatment at Day 0, 1 and 7. Results: After 7 days, the mean plaque index for the first group was 0.76±0.38 compared with a mean plaque index of 1.43±0.56 for the second group. The difference in plaque scores between the groups was statistically significant. Conclusion: the results of this study showed that rinsing with an alcohol base 0.12% Chlorhexidine mouthrinse is significantly different from rinsing with an alcohol free 0.1% Chlorhexidine mouthrinse on plaque inhibition. Key words:Chlorhexidine, dental plaque, mouthrinse, alcohol, formaldehyde.
Journal of Human Behavior in The Social Environment | 2017
Amal Bouziane; Samir Ahid; Redouane Abouqal
Department of Periodontology, Faculty of Dental Medicine, Mohammed V University in Rabat, Rabat, Morocco; Pharmacoeconomics Pharmacoepidemiology Research Team, Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco; Laboratory of Biostatistics, Clinical Research, and Epidemiology. Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco
Journal of Periodontal & Implant Science | 2014
Amal Bouziane; Latifa Benrachadi; Redouane Abouqal; Oumkeltoum Ennibi
Purpose Aggressive periodontitis, especially in its severe form, was traditionally considered to have an unfavourable prognosis. It required a complex treatment and its stabilization was often achieved by surgical therapy. The aim of this study was to investigate the results of nonsurgical periodontal treatment in severe generalized forms of aggressive periodontitis. Methods Patients with advanced generalized aggressive periodontitis were included in the study. Probing depth (PD) of pockets ≥7 mm and clinical attachment level (CAL) of sites with attachment loss ≥5 mm were measured at baseline before nonsurgical periodontal treatment, at re-evaluation, and after treatment. The following other parameters were recorded: resolution of inflammation and bone fill. We compared the baseline values with re-evaluation and posttreatment values using the Friedman test. The Wilcoxon test with the Bonferroni correction was used for both re-evaluation and posttreatment values. Results Seven patients with 266 periodontal sites were examined. A significant difference was found between values, reported as medians with interquartile ranges, for PD at baseline (7.94 [7.33-8.19] mm) and both re-evaluation (4.33 [3.63-5.08] mm) and posttreatment (3.54 [3.33-4.11] mm) values (P=0.002). A significant difference was also found between values for CAL at baseline (9.02 [7.5-9.2] mm) and both re-evaluation (6.55 [6.30-6.87] mm) and posttreatment (6.45 [5.70-6.61] mm) (P=0.002). Inflammation was resolved and angular bone defects were repaired in all cases. Conclusions These therapeutic results suggest that this form of periodontitis could have positive outcomes after nonsurgical periodontal treatment. The reparative potential of tissue affected by severe aggressive periodontitis should encourage clinicians to save apparently hopeless teeth in cases of this form of periodontitis. Graphical Abstract
Journal of Clinical Periodontology | 2012
Amal Bouziane; Samir Ahid; Redouane Abouqal; Oumkeltoum Ennibi
The Breast | 2017
Soufiane Berhili; Selma Kadiri; Amal Bouziane; Abdallah Aissa; Elamin Marnouche; Etienne Ogandaga; Yassine Echchikhi; Asmae Touil; Hasna Loughlimi; Ibtissam Lahdiri; Sanae El Majjaoui; Hanan El Kacemi; T. Kebdani; Noureddine Benjaafar
Archive | 2012
Bouziane A; Samir Ahid; Amal Bouziane; Redouane Abouqal; Oumkeltoum Ennibi
Revue d'odonto-stomatologie | 2005
Amal Bouziane; Latifa Benrachadi; Lamia Abdellaoui; Oumkeltoum Ennibi; N. Benzarti
International Journal of Pharmacy and Pharmaceutical Sciences | 2017
Leila Lakhdar; Abdellah Farah; Idriss Lahlou; Sana Rida; Amal Bouziane; Oumkeltoum Ennibi
Dental update | 2015
Amal Bouziane; Latifa Benrachadi; Oumkeltoum Ennibi